ACADIA Pharmaceuticals said on Monday that it has hired Dr. James "Randy" Owen to be its new senior vice president for clinical development and chief medical officer.
ACADIA is a biopharmaceutical company focusing on the development of medicines to treat central nervous system disorders. Owen will be responsible for shepherding clinical development programs for ACADIA's product candidates. Owen will report directly to Dr. Serge Stankovic, executive vice president and head of research and development.
Before his appointment with ACADIA, Owen served as vice president of U.S. clinical affairs at Lundbeck LLC. During his time with Lundbeck, from 2010 to 2016, he led a team of medical experts and scientists that made noteworthy contributions in the development of drugs to treat neurological and psychiatric disorders, including Alzheimer's disease, schizophrenia and the effects from a stroke. Before Lundbeck, Owen was the group director of global clinical research at Bristol-Myers Squibb. Owen earned his bachelor's at Haverford College, before receiving his M.D. at East Tennessee State University's Quillen College of Medicine.
Alerts Sign-up